Home » Newsletters » BioWorld

BioWorld

Sep. 25, 1991

View Archived Issues

MERCK SEEKS NATURAL DRUG SOURCES

ENROLLMENT BEGINS FOR AIDS TRIALS

JOINT U.S./CANADIAN REVIEW OF DEPRENYL

PHARMATEC TO RAISE $5.5 MILLION

CELLPRO GROSSES $33 MILLION IN IPO

CROP GENETICS TO ACQUIRE ESPRO

REPORT: PRODUCT FLOW WILL DRIVE INDUSTRY

MONTGOMERY SECURITIES CONFERENCE

SYNERGEN CEO SAYS ANTRIL WILL COMPETE

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026